A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
Clinical trial NCT07734064 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07734064
- Sponsor
- Astellas Institute for Regenerative Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-31
- Primary completion
- 2029-09-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.